Stocks
Health Care
lrmr
Larimar Therapeutics
NASDAQ: LRMR
+2.39 (+64.63%)
6.075
USD
At close at Feb 25, 20:38 UTC
Income Statement
Revenue
-
Gross Profit
-
Operating Income
-90.89M
Pretax Income
-132.00M
Net Income
-80.60M
EBITDA
-80.47M
EBIT
-80.60M
Earnings Per Share
-1.31
Balance Sheet
Cash & Cash Equivalents
53.84M
Total Debt
5.35M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
203.12M
Book Value Per Share
3.18
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.